![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/16bc98940a34f0991f9ca5e7ccbfa6889fec078f-1634x909.jpg?w=350&fit=crop&auto=format)
Publication|Videos|May 30, 2024
Recent Pharma Trends, EU Annex 1, and More with Syntegon
Author(s)Syntegon Pharma Technology
At a recent INTERPHEX conference, Laura Moody (Director of Product Management, Pharma North America, Syntegon) shared some insights into current trends in the pharmaceutical industry, including the EU Annex 1.
Between bigger commitments to sustainability, updated regulatory requirements, and increasingly innovative equipment, the pharmaceutical industry is undergoing a great deal of change. To learn more, Pharmaceutical Technology spoke with Laura Moody, Director of Product Management for Pharma North America at Syntegon. Watch this video to learn more about:
- The current landscape of the pharmaceutical industry, including current trends;
- How the EU Annex 1 affects pharmaceutical companies;
- How Syntegon supports pharmaceutical companies in drug making processes.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
![[Rishi Pimentel, gChem]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/01d391920288b8bd8b751988988b5a6544a6ddaa-1629x908.jpg?w=350&fit=crop&auto=format)
![[Nigel Langley]](https://cdn.sanity.io/images/0vv8moc6/pharmtech/e2c0137d8224aaa1f14c0f1af43b58d21f4541dd-1768x904.jpg?w=350&fit=crop&auto=format)
